Nivolumab(N)‐AVD improves progression‐free survival compared to brentuximab vedotin(BV)‐AVD in advanced stage (AS) classic Hodgkin lymphoma (HL): Results of SWOG S1826 Meeting Abstract
| Authors: | Herrera, A. F.; LeBlanc, M.; Castellino, S. M.; Li, H.; Rutherford, S. C.; Evens, A. M.; Davison, K.; Punnett, A.; Hodgson, D.; Parsons, S. K.; Ahmed, S.; Casulo, C.; Bartlett, N. L.; Tuscano, J. M.; Mei, M. G.; Hess, B. T.; Jacobs, R.; Saeed, H.; Torka, P.; Hu, B.; Moskowitz, C.; Kaur, S.; Goyal, G.; Forlenza, C.; Doan, A.; Lamble, A.; Kumar, P.; Chowdhury, S.; Brinker, B.; Sharma, N.; Singh, A.; Blum, K.; Perry, A. M.; Kovach, A.; Constine, L. S.; Kostakoglu Shields, L.; Prica, A.; Little, R. F.; Shipp, M. A.; Crump, M.; Kahl, B.; Leonard, J. P.; Smith, S. M.; Song, J. Y.; Kelly, K. M.; Friedberg, J. W. |
| Abstract Title: | Nivolumab(N)‐AVD improves progression‐free survival compared to brentuximab vedotin(BV)‐AVD in advanced stage (AS) classic Hodgkin lymphoma (HL): Results of SWOG S1826 |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 33 |
| End Page: | 35 |
| Language: | English |
| DOI: | 10.1002/hon.3163_5 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 005 -- Source: Cinahl |
